Overview Vision & Strategy Bio Revolution Innovations Consumer Health Trends Rise of Self-Care Outperforming the Market Pharmaceutical Trends Growing Demand Breakthroughs in the Pipeline Trends in Agriculture Growth Potential Leading Global R&D Investor News Ad Hoc Events & Presentations Annual Stockholders' Meeting Notice of the Meeting & Agenda Stockholders’ Portal Countermotions and Proposals for Election Stockholder Statements Right to speak Right of information Right to object How to Vote Voting Results ASM-Services & -Downloads ASM Archive Events Archive Financial Reports Quarterly Reports Annual Reports Bayer AG Financial Statements Compensation Reports Shareholder Information Stock Chart Analyst Consensus Dividends Return Calculator Voting Rights Announcements Overview Archive ADR Program Glossary Debt Corporate Governance Duties and Activities of the Board of Management Supervisory Board Disclosure of Managers' Transactions Approach to Tax Control Corporate Compliance Links & Downloads Document Download Tool Contact Us Investor Conference Call // May 11, 2023 // 2:00 p.m. CEST Q1 2023 Results Investor News May 11th, 2023 Bayer: Slow start to the year as expected MORE Recording of the Webcast Presentation Charts (PDF, 1,977 KB) Press Release Quarterly Statement First Quarter 2023 (PDF, 245 KB) Transcript (PDF, 243 KB) Aide Memoire (PDF, 201 KB) FX-Tool (xlsx, 170 KB) Werner Baumann CEO of Bayer AG Wolfgang Nickl CFO of Bayer AG Services Please Choose Contact IR Team Newsletter Download Tool Q1 2023 Aide Memoire & FX Tool Download Aide Memoire Download FX Tool Current Links Annual Stockholders' Meeting 2023 Current Reports Quarterly Statements / Half-Year Reports Annual Reports
